Cargando…
Lkb1 Loss Promotes Tumor Progression of BRAF(V600E)-Induced Lung Adenomas
Aberrant activation of MAP kinase signaling pathway and loss of tumor suppressor LKB1 have been implicated in lung cancer development and progression. Although oncogenic KRAS mutations are frequent, BRAF mutations (BRAF(V600E)) are found in 3% of human non-small cell lung cancers. Contrary to KRAS m...
Autores principales: | González-Sánchez, Elena, Martín-Caballero, Juan, Flores, Juana María, Hernández-Losa, Javier, Cortés, Javier, Mares, Roso, Barbacid, Mariano, Recio, Juan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692542/ https://www.ncbi.nlm.nih.gov/pubmed/23825589 http://dx.doi.org/10.1371/journal.pone.0066933 |
Ejemplares similares
-
Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAF(V600E)
por: Esteve-Puig, Rosaura, et al.
Publicado: (2009) -
A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21(WAF1/CIP1)) Degradation
por: Esteve-Puig, Rosaura, et al.
Publicado: (2014) -
Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines
por: Teixidó, Cristina, et al.
Publicado: (2013) -
High frequency of BRAF V600E mutations in ameloblastoma
por: Kurppa, Kari J, et al.
Publicado: (2014) -
BRAF V600E mutational load as a prognosis biomarker in malignant melanoma
por: Sevilla, Arrate, et al.
Publicado: (2020)